on to bridging inter-disciplinary divides, the conference offered participants an affordable venue for experts to meet: Many industry events are prohibitively expensive for a lot of social scientists, particularly junior researchers. Another positive aspect of the event was that we were able to host one of the neurotechnology industrys leading representatives at an accessible event open to researchers from a variety of disciplines. This fostered a large amount of productive dialogue.
According to McGoey, increasing cross-disciplinary literacy is a continuing challenge since experts with different perspectives on the implications of neuroscience have few opportunities to meet, a challenge which the ENSN seeks to resolve.
Future events designed to bridge this divide include an invitational workshop to be held at Harvard University in May, providing European members of the network with an opportunity to engage with researchers in the US. In addition, Dr. Giovanni Frazzetto, co-founder and advisory expert to ENSN, is chairing a neuroschool to take place in Rome in September. The first inter-disciplinary neuroschool, an ENSN initiative, will bring together junior researchers, neuroscientists and social scientists to exchange disciplinary skills. The participants will receive hands-on training on behavioural genetics and contextualization in contemporary society, focusing on the genetic disposition of certain anxiety and psychiatric disorders. Finally, another European conference is planned in Portugal in spring 2009. A call for applications inviting individual researchers to submit abstracts to the conference in Portugal will be issued by the ENSN shortly.
'/>"/>
Page: 1 2 Related medicine news :1.
Eligard(R) six-month formulation successfully completes European approval procedure2.
Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma3.
Medical Services International Inc. Completes Testing for European Union (EU) Application4.
Labopharm To Present Poster On Onset Of Analgesic Effect Of Once-Daily Tramadol At Congress Of The European Society Of Regional Anaesthesia And Pain Therapy5.
Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes6.
Launch of second European Cancer Research Funding survey7.
European directive will halt use of MRI scans; cancer diagnosis and treatment will suffer8.
Pharsight to Host European Software Conference9.
OmniGuide Begins European Commercialization10.
Paving the way for future pan-European clinical trials11.
US, European cancer educators gather in Alabama for meeting